Evidence map›Paper›PMID 42428059›Full record

ArticlemedRxiv : the preprint server for health sciences2026

The national burden from O'nyong'nyong and chikungunya viruses in Cameroon.

Ngu Njei Abanda, Anchita Puri, Michael White, Laura Garcia, Camille Lambert, Sorel Jakpou, Jules Brice Tchatchueng Mbougua, Oscar Cortes-Azuero, Scott C Weaver, Henrik Salje and 1 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ngu Njei AbandaCentre Pasteur du Cameroun, Yaoundé, Cameroun.
Anchita PuriDepartment of Genetics, University of Cambridge, UK.
Michael WhiteInfectious Disease Epidemiology and Analytics G5 Unit, Department of Global Health, Institut Pasteur, Université Paris-Cité, INSERM U1347, Paris, France.
Laura GarciaInfectious Disease Epidemiology and Analytics G5 Unit, Department of Global Health, Institut Pasteur, Université Paris-Cité, INSERM U1347, Paris, France.
Camille LambertInfectious Disease Epidemiology and Analytics G5 Unit, Department of Global Health, Institut Pasteur, Université Paris-Cité, INSERM U1347, Paris, France.
Sorel JakpouCentre Pasteur du Cameroun, Yaoundé, Cameroun.
Jules Brice Tchatchueng MbouguaCentre Pasteur du Cameroun, Yaoundé, Cameroun.
Oscar Cortes-AzueroDepartment of Genetics, University of Cambridge, UK.
Scott C WeaverUniversity of Texas Medical Branch, Galveston, United States of America.
Henrik SaljeDepartment of Genetics, University of Cambridge, UK.
Richard NjouomCentre Pasteur du Cameroun, Yaoundé, Cameroun.

Funding

Emerging Infectious Diseases Research Centers Coordination Center (EIDRC CC)U01AI151378 · NIAID · RESEARCH TRIANGLE INSTITUTE · PI Gregory D Sempowski · 2020 to 2026
$14.7M
West African Center for Emerging Infectious DiseasesU01AI151801 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Robert W Cross, Scott C Weaver · 2020 to 2026
$10.1M
NIAID NIH HHS U01 AI151378NIAID NIH HHS U01 AI151801Wellcome Trust
6 · The paper itself

Abstract

O'nyong-nyong (ONNV) and chikungunya (CHIKV) are arboviruses that have been identified nearly throughout Africa. However, the disease burden from the viruses has been rarely quantified as surveillance systems are poorly equipped to identify cases. Here, we tested 6,324 serum samples collected as part of the Yellow Fever testing program between 2010 and 2023 in individuals of all ages from all the health districts of Cameroon. We used a novel multiplex assay that incorporated antigens from three alphaviruses (ONNV, CHIKV and MAYV) and mathematical models that explicitly consider cross-reactivity to reconstruct individual and population infection histories for each virus. We found that despite no cases reported in Cameroon, ONNV has circulated endemically across the country for decades with an average of 332,000 annual infections and 8 million individuals with a history of infection. By contrast, we found evidence of only sporadic CHIKV outbreaks, with an estimated prevalence of 1.7%. Models that did not explicitly consider cross-reactivity between the alphaviruses lead to incorrect conclusions about the circulation of the viruses. This work highlights the need for systematic efforts to identify ONNV incident cases and the development of a vaccine development investment case against this neglected pathogen.

Identifiers

PMID42428059
PMCPMC13345575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.